Stock Events

Stock Events

Search...

Marker Therapeutics (MRKR) Q2 2023 Earnings

14AugConfirmed

Nov 22

Q4 2022

Q1 2023

Q2 2023

-0.8

-0.56

-0.32

-0.08

Details

Expected EPS

N/A

Actual EPS

-0.47

Surprise EPS

-0.47

Surprise Percent

+∞%

Description

Marker Therapeutics (MRKR) has reported earnings of -0.47 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.